Farnham Family Services to build new Oswego office
OSWEGO, N.Y. — Farnham Family Services says it plans to build a new 16,000-square-foot facility in Oswego next summer that will serve as its future home in the Port City.
Source: cnybj.com
📰 Candy Herbert News
Candy Herbert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Candy Herbert. Real-time updates on events, politics, business and more.
Invizius Announces Appointment of World-Renowned Nephrologist Professor Bernard Canaud to its Clinical Advisory Board
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, is pleased to announce the...
Source: prnewswire.com
Invizius Receives MHRA Approval to Commence First-in-Human Clinical Study of H-Guard® Priming Solution
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and...
Source: prnewswire.com
Invizius announces 'Angry Blood' Haemodialysis Study and recruits its 300th patient
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and...
Source: prnewswire.com
Invizius' 'angry blood' research recruits 300th patient
525-patient trial intends to assess ‘complement activation’ during HD in patients with end stage renal failure - News - PharmaTimes
Source: pharmatimes.com
York: Andy Herbert nominated for Community Pride Award
A former York head teacher has been nominated for an award celebrating his service to the community.
Source: yorkpress.co.uk
NZ covid vaccine developer shuts up shop
The patent that protects the ground-breaking technology ends in a few weeks.
Source: nzherald.co.nz
Head teacher at Clifton with Rawcliffe School, York, retires
Andy Herbert, the head teacher at Clifton with Rawcliffe School in York, has retired.
Source: yorkpress.co.uk
Invizius Awarded Second Biomedical Catalyst Grant to Research Peritoneal Dialysis Option for its H-Guard® Technology
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today...
Glasgow City United Kingdom City Of Candy Herbert Prnewswire Invizius Limited University Of Edinburgh
Source: prnewswire.com
Invizius Awarded Second Biomedical Catalyst Grant to Research Peritoneal Dialysis Option for its H-Guard® Technology
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today...
Glasgow City United Kingdom City Of Candy Herbert Prnewswire Invizius Limited University Of Edinburgh
Source: prnewswire.com